Compound Profile
Abilify 15 Abdi Ibragim is an aripiprazole-based research compound developed for laboratory investigation of dopamine and serotonin receptor systems. As a benzisoxazole derivative, this formulation enables researchers at Stroid UK Shop to examine atypical antipsychotic mechanisms in controlled experimental settings. The compound represents a third-generation antipsychotic class with unique partial agonist properties at dopamine D2 receptors, distinguishing it from traditional receptor antagonists used in neurochemical research applications.
Laboratory Research Applications
Research scientists investigate this compound for its distinctive pharmacological profile in neurotransmitter modulation studies. The formulation demonstrates partial agonist activity at dopamine D2 and D3 receptors alongside 5-HT1A receptors, while functioning as an antagonist at 5-HT2A receptors in cellular assays. Investigators studying dopaminergic pathway balance examine how this compound’s intrinsic activity stabilises neurotransmitter fluctuations without causing complete receptor blockade. Laboratories researching antipsychotic drugs and aripiprazole utilise this formulation to evaluate novel therapeutic mechanisms. Additional research applications include analysis of metabolic pathways, as this compound shows reduced propensity for weight gain and glucose dysregulation compared to classical antipsychotics in preclinical models. Studies investigating prolactin regulation examine this compound’s minimal impact on prolactin secretion, while cardiovascular research explores its neutral effects on cardiac conduction parameters. Comparative studies with compounds available in SARMs and peptides research categories provide valuable insights into receptor selectivity profiles.
Technical Specifications
| Active Compound | Aripiprazole |
|---|---|
| CAS Number | 129722-12-9 |
| Molecular Formula | C₂₃H₂₇Cl₂N₃O₂ |
| Molecular Weight | 448.39 g/mol |
| Storage Requirements | Room temperature, dry environment |
| Research Classification | Dopamine system modulator |
Research Compliance
This product is supplied exclusively for in-vitro laboratory research purposes. Not for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory safety protocols and regulatory compliance within their institutional frameworks.
